Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

779
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
779
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: The immune microenvironment-microbiome interactions in peri-implantitis and periodontitis.

Frontiers in cellular and infection microbiology·2026
Same author

Lonely boats swaying in the storm: experiences and supportive needs of adult only-children confronting parental end-of-life care: a qualitative study.

BMC palliative care·2026
Same author

Hypoxia-induced exosomal LNCOC1 orchestrates bladder cancer progression via the YBX1/PIK3CA axis and serves as a potential liquid biopsy biomarker.

Cellular oncology (Dordrecht, Netherlands)·2026
Same author

[Exploration of prescription patterns of TCM in treatment of cerebral small vessel disease based on latent structure model combined with association rules].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Fluorescent sensors for volatile acids: design strategies and sensing mechanisms.

Materials horizons·2026
Same author

Magnolol alleviates oxidative stress injury by modulating microglia activation and polarization in an experimental rat model of spinal cord injury.

The journal of spinal cord medicine·2026

Related Experiment Video

Updated: Jul 5, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

A few-shot link prediction framework to drug repurposing using multi-level attention network.

Chenglin Yang1, Xianlai Chen2, Jincai Huang2

  • 1Big Data Institute, Central South University, Changsha, 410083, China; School of Life Sciences, Central South University, Changsha, 410083, China.

Computers in Biology and Medicine
|January 20, 2024
PubMed
Summary

This study introduces a novel meta-learning framework for drug repurposing, enhancing few-shot link prediction in medical knowledge graphs. The multi-level attention network effectively identifies new drug indications, overcoming data sparsity challenges.

Keywords:
Drug repurposingFew-shot link predictionModel-agnostic meta-learningMulti-level attention networkSet transformer

More Related Videos

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
06:37

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

Published on: December 15, 2023

3.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

758

Related Experiment Videos

Last Updated: Jul 5, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
06:37

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

Published on: December 15, 2023

3.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

758

Area of Science:

  • Computational Biology
  • Pharmacology
  • Artificial Intelligence

Background:

  • Drug repurposing accelerates the discovery of new therapeutic uses for existing drugs.
  • Link prediction in medical knowledge graphs models drug-disease relationships.
  • Few-shot learning is crucial due to the rarity of novel drug-disease links.

Purpose of the Study:

  • To develop an effective few-shot link prediction framework for drug repurposing.
  • To address challenges posed by sparse data and weak interactions in medical knowledge graphs.
  • To improve the accuracy and efficiency of identifying novel drug indications.

Main Methods:

  • A meta-learning framework integrating a multi-level attention network (MLAN).
  • Utilized gating mechanisms and graph attention networks to filter noise and highlight relevant neighborhood information.
  • Employed a set transformer for robust triplet-level interaction learning and a model-agnostic meta-learning strategy for rapid optimization.

Main Results:

  • The proposed MLAN-based framework demonstrated significant advantages over state-of-the-art few-shot link prediction methods.
  • Achieved superior performance on specialized few-shot medical link prediction datasets (COVID19-One, BIOKG-One).
  • Validated the framework's ability to capture valuable information in low-data scenarios.

Conclusions:

  • The unified meta-learning framework effectively addresses challenges in few-shot drug repurposing.
  • The MLAN approach provides valuable insights for predicting novel drug-disease relationships.
  • This method offers a promising direction for accelerating drug discovery through advanced AI techniques.